Elevance Health (ELV) Interest Expenses (2009 - 2026)

Elevance Health (ELV) has reported Interest Expenses for 18 consecutive years, with $187.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Interest Expenses rose 14.72% year-over-year to $187.0 million in Q2 2026; TTM through Jun 2026 was $187.0 million, a 14.72% increase from a year earlier, with the FY2025 full-year figure at $167.0 million, down 8.74% from the prior year.
• Interest Expenses was $187.0 million for Q2 2026 at Elevance Health, down from $205.0 million in the prior quarter.
• Over five years, Interest Expenses peaked at $212.0 million in Q4 2023 and troughed at $137.0 million in Q2 2022.
• A 5-year average of $173.7 million and a median of $177.5 million in 2024 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses jumped 42.28% in 2024 and retreated 16.04% in 2025, its largest moves.
• Over 5 years, Interest Expenses stood at $152.0 million in 2022, then jumped by 39.47% to $212.0 million in 2023, then slipped by 13.68% to $183.0 million in 2024, then fell by 8.74% to $167.0 million in 2025, then grew by 11.98% to $187.0 million in 2026.
• The last three Interest Expenses figures came in at $187.0 million (Q2 2026), $205.0 million (Q1 2026), and $167.0 million (Q4 2025), per Business Quant data.